Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
Status: | Recruiting |
---|---|
Conditions: | Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease |
Therapuetic Areas: | Nephrology / Urology |
Healthy: | No |
Age Range: | 18 - 85 |
Updated: | 3/16/2019 |
Start Date: | July 1, 2018 |
End Date: | December 2023 |
Contact: | Tammy Sirich, MD |
Email: | tsirich@stanford.edu |
Phone: | 650-493-5000 |
The study will determine the efficacy of twice weekly hemodialysis in patients with residual
kidney function.
kidney function.
Hemodialysis patients who have residual kidney function will undergo two 4-week study (twice
weekly versus thrice weekly hemodialysis). Blood, urine, and dialysate samples will be
collected at the end of each study period to determine adequacy of treatment and to assess
uremic solute levels. Participants will complete quality of life questionnaires and cognitive
paper tests. Food records and medications may be monitored.
weekly versus thrice weekly hemodialysis). Blood, urine, and dialysate samples will be
collected at the end of each study period to determine adequacy of treatment and to assess
uremic solute levels. Participants will complete quality of life questionnaires and cognitive
paper tests. Food records and medications may be monitored.
Inclusion Criteria:
- Stable dialysis patients able to provide consent
Exclusion Criteria:
- Use of antibiotics for last two months or expected antibiotic use
- Recent hospitalization or other event resulting in instability of food intake
- Residual kidney function < 2.5 mL/min
We found this trial at
3
sites
VA Palo Alto Health Care System The VA Palo Alto Health Care System (VAPAHCS) consists...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials